openwiki-wiki/themes.md

# Themes

Recurring topics, signals, and trends observed across Robin's sources. Detailed evidence and item lists live on the relevant `/sources/<connector>.md` or topic page; this file is the index.

Index kept narrow by design: only themes that map to Robin's actual work (life-sciences PM at Femtobiomed / 9X Bio, CelVivo / 3Brain / Cellink / Femtobiomed product portfolio, plus the AI agent tooling stack that drives his daily workflow). High-engagement HN topics outside this scope are noted in `/sources/hackernews.md` under "Themes not refreshed this run" but are not promoted to theme rows here.

| Topic key | Theme / Signal | First seen | Last seen | Confidence | Sources | Evidence count | Status | Evidence |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| `class-organoid-3d-bioprinting` | Recurring organoid, 3D bioprinting, and 3D-cell-culture automation coverage; this window adds a 2026-07-28 HN drug-discovery essay (owlposting "Why haven't organoids solved all of drug discovery?", 9 pts), a 2026-07-27 Oxford Academic review on 3D-bioprinted organoids, a 2026-07-22 Sage review on bioprinting-enabled organoids, a 2026-07-27 Pluristyx iPSC + aerospace clinical-grade hepatocyte manufacturing partnership, the first vendor-anchored CelVivo ClinoReactor co-marketing signal (TheWell Bioscience xeno-free workflow pages), and the first vendor-anchored Cellink BIO X Gen 3 / BIO X6 signal (Nuclear Mechano-Oncology install + CELLINK LinkedIn U. Miami reference + third-party market report) plus GEN "Large Bioprinted Tissues Get a Precision Boost" (2026-07-29) and MDPI Cells "Rapid Volumetric Bioprinting Coupled with Dynamic Perfusion Enhances Human Hepatic Organoid Toxicity Testing" (2026-07-27) on top of the prior Nature / HN evidence; pull 7 (2026-07-30) adds FDA NAMs framework (2026-07-27, organ-on-chip included among New Approach Methodologies alongside June 2026 cell/gene-therapy draft guidance), Molecular Cancer patient-derived 3D-bioprinted primary liver cancer (Peking Union Medical College Hospital, 2026-07-28), and npj Biomedical Innovations microvasculature bioprinting review (2026-07-29); still mostly application-domain plus two vendor-channel signals | 2026-07-16 | 2026-07-30 | source-backed | hackernews, web-search | 22+ | active | [HN: 49083799 drug-discovery essay 2026-07-28](/sources/hackernews.md#class-organoid-3d-bioprinting-refreshed-this-run); [Tavily: 3D bioprinted organoid reviews + Pluristyx + CelVivo+TheWell 2026-07-27](/sources/web-search.md#2026-07-27-1804-pull); [Tavily: Cellink BIO X Gen 3 / BIO X6 + CN Bio / NASA AVATAR OOC + GEN bioprinting 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull); [Tavily: FDA NAMs + Peking Union 3D-bioprinted liver cancer + npj microvasculature 2026-07-30](/sources/web-search.md#2026-07-30-1804-pull) |
| `china-cde-cell-gene-therapy-rules-2026` | China CDE (under NMPA) published technical guidelines defining scope & classification of cell and gene therapy drugs; standardizes CMC planning for Chinese pharma/CDMO/biotech customers | 2026-07-24 | 2026-07-24 | source-backed | web-search | 1 | watchlist | [Tavily: cisema.com 2026-07-24](/sources/web-search.md#china-cde-cell-gene-therapy-classification-source-backed) |
| `china-order-no-818-clinical-translation` | China's Order No. 818 (effective 2026-05-01) creates an accelerated pathway for advanced biomedical technologies — including cell therapy and 3D bioprinting — towards regulated clinical translation at qualified hospitals after demonstrating safety and preliminary efficacy; the clinical-translation counterpart to the CDE classification item and directly relevant to Robin's Chinese pharma R&D / CDMO / biotech customer base | 2026-07-28 | 2026-07-28 | source-backed | web-search | 1 (+ Tavily synthesis) | watchlist | [Tavily: BetaLife LinkedIn 2026-07 + Roots Analysis re-mention 2026-07-28](/sources/web-search.md#china-order-no-818--accelerated-clinical-translation-pathway--source-backed) |
| `MiniMax-m3` | MiniMax-M3 (1M context multimodal) HuggingFace model card + Twitter launch; the daily-driver inference provider behind every OpenWiki run and most of Robin's agent work; haimaker.ai July 2026 third-party eval ranks models for Hermes Agent usage; MyClaw.ai 2026-07-29 confirms M3 + M2.7 are the operational models for both OpenClaw and Hermes, with M3 supporting multimodal (image, video, music, speech, web search) | 2026-07-16 | 2026-07-29 | watchlist | hackernews, web-search | 5 | watchlist | [HN: M3 model cluster (huggingface + twitter)](/sources/hackernews.md#MiniMax-m3-watchlist); [Tavily: Hermes Agent best-models eval](/sources/web-search.md#hermes-agent-best-models-eval-source-backed-workflow-tooling-low-priority); [Tavily: MyClaw OpenClaw vs MiniMax Agent 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull) |
| `hermes-agent-v0-19-quicksilver` | Hermes Agent v0.19 "Quicksilver" release (2026-07-25): first-token delay 4.3s → 0.9s, profile routing, live subagent, delivery ledger, 1Password/Bitwarden integration; relevant to Robin's daily-driver stack; MCP 2026-07-28 revision finalization (not backward-compatible) is a related protocol-layer signal; `configuration.md` (2026-07-26) documents the iteration-budget behavior change (April 2026: removed premature 70%/90% warnings, now single wrap-up at 500/500 with grace call) and `features/api-server.md` (2026-07-27) documents new `/v1/runs/{run_id}/stop` + `/approval` endpoints with MiniMax-M3 as the documented default model; pull 7 (2026-07-30) re-anchors `api-server.md` with a new per-profile `API_SERVER_KEY` breaking-change warning and a runs API for long-form sessions, and adds a third-party Hermes Atlas "State of Hermes Agent — July 2026" report | 2026-07-25 | 2026-07-30 | source-backed | web-search | 8 | active | [Tavily: Hermes v0.19 Quicksilver + MCP revision 2026-07-27](/sources/web-search.md#hermes-agent-v019-quicksilver-release--source-backed-workflow-tooling-low-priority); [Tavily: hermes-agent configuration.md + api-server.md + MyClaw 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull); [Tavily: api-server.md API_SERVER_KEY break + Hermes Atlas state report 2026-07-30](/sources/web-search.md#2026-07-30-1804-pull) |
| `openwiki-brand` | `langchain-ai/openwiki` (96 pts) — same product family as Robin's OpenWiki; high-engagement on HN | 2026-07-16 | 2026-07-16 | source-backed | hackernews | 1 (+ 2 adjacent wrappers) | watchlist | [HN: openwiki cluster](/sources/hackernews.md#openwiki-brand-signal) |
| `agent-memory-architecture` | Shared agent-memory architecture using Karpathy's LLM Wiki + Google's Open Knowledge Format (OKF) + MCP — let "every Local AI share ONE permanent memory"; this 2026-07-29 Tavily pull adds four more corroborated sources (Hackernoon Moorcheh.ai "Agent Memory Has a Lock-In Problem. Open Formats Are How We Fix It." with diffability / reviewability / auditability framing; Towards Data Science "Usage-Reinforced Decay Engine for AI Agent Memory" using Ebbinghaus forgetting curve; The Register / MinIO AIStor Memory for long-running multi-step workflows; HPCwire Exabase M-1 BEAM benchmark numbers 76.9% / 75.0% / 68.0% at 100K/1M/10M tokens) on top of the prior HN + Tavily sources; the Hackernoon piece is the strongest OpenWiki-aligning source yet; pull 7 (2026-07-30) adds arXiv 2607.24759v1 "A Templated Substrate for Heterogeneous Collaborative" + rohitg00 LLM Wiki v2 (extending Karpathy's LLM Wiki pattern with lessons from building agentmemory) + Pi `@zosmaai/pi-llm-wiki` package + MinIO AIStor Memory (HPCwire 2026-07-29 + SiliconANGLE 2026-07-30) — cluster is now 14+ distinct sources | 2026-07-26 | 2026-07-30 | source-backed | hackernews, web-search | 14+ | active | [HN: 49059959, 49059889, 49060215](/sources/hackernews.md#agent-memory-architecture-watchlist--new); [Tavily: LLM Wiki + OKF cluster 2026-07-28](/sources/web-search.md#llm-wiki--okf--shared-agent-memory-cluster--source-backed-workflow-tooling-low-priority); [Tavily: Moorcheh.ai + TDS + MinIO + Exabase cluster 2026-07-29](/sources/web-search.md#2026-07-29-1803-pull); [Tavily: arXiv 2607.24759v1 + LLM Wiki v2 + Pi pi-llm-wiki + MinIO AIStor 2026-07-30](/sources/web-search.md#2026-07-30-1804-pull) |

## Notes

- Promote a watchlist signal to a full theme row only after it recurs or comes from a high-quality source.
- Keep prose here to 1-2 sentences per theme; link out for detail.
- HN evidence rules: low-engagement items are watchlist by default; promotion requires recurrence, strong engagement, or corroboration.
- **Scope discipline (per `~/.openwiki/INSTRUCTIONS.md`)**: themes that do not anchor to one of (a) the 4 vendor product lines (CelVivo / 3Brain / Cellink / Femtobiomed), (b) Robin's active customers, (c) the 4 application domains (3D cell culture, 3D bioprinting, neuroscience in vitro, organoid workflows), or (d) the daily-driver AI agent stack (Hermes Agent, MiniMax, OpenWiki, RAGFlow, NocoDB, SeaFile) → drop from this index even when HN engagement is high.
- Topic rows like `coding-agent-tooling`, `context-engineering-claude5`, `ai-safety-debate`, `open-weight-ai`, `computer-use-agents`, `codex-openai`, `llm-on-old-hardware`, `local-LLM-stream` are deliberately absent here. Their evidence lives in `/sources/hackernews.md` for traceability but they do not earn a `themes.md` row.
- Vendor brand signal: CelVivo, 3Brain, Cellink, ClinoStar, ClinoReactor, Femtobiomed CellShot/CellPick/TriArm still have **no material Hacker News footprint** (see `/sources/hackernews.md` query-hit table). The web-search connector (Tavily) is the better lane for these — see `/sources/web-search.md` for the first pull on 2026-07-26.